Table 1

Sample information
Sample*
 Age (years)
 Sex
 28S/18S ratio†
 GAPDH 5'/3' ratio‡
 Expressed probe sets (%)§
 Diagnosis
 Epilepsy
 Types of seizures
HA1
 70
 M
 1.2
 0.445
 50.6
 -
 -
 -
HA3
 45
 M
 1.6
 0.637
 49.7
 -
 -
 -
HA4
 45
 M
 1.2
 0.507
 49.4
 -
 -
 -
HA5
 54
 F
 1.6
 0.712
 51.7
 -
 -
 -
HR1
 45
 M
 1.1
 0.520
 50.5
 Anaplastisches Oligo WHO III
 Yes
 Simple partial
HR2
 39
 F
 1.3
 0.700
 50.2
 Glioblastoma
 Yes
 Simple and complex partial, GM
HR3
 61
 M
 1.6
 0.774
 53.8
 Glioblastoma
 Yes
 Simple and complex partial
HR4
 51
 F
 1.6
 0.697
 49.5
 Ammon's horn sclerosis
 Yes
 Simple and complex partial, GM
HR5
 13
 M
 1.4
 0.778
 47.1
 Ganglioglioma
 Yes
 Complex partial
HR6
 83
 F
 1.3
 0.817
 50.0
 Atpisches Meningeom Grad II
 No
 -
CA1
 45
 M
 1.4
 0.870
 51.0
 -
 -
 -
CA2
 45
 M
 1.4
 0.841
 51.4
 -
 -
 -
CA3
 48
 M
 1.5
 0.865
 53.2
 -
 -
 -
CA5
 70
 M
 1.4
 0.669
 47.2
 -
 -
 -
CA6
 82
 F
 1.7
 0.690
 47.7
 -
 -
 -
CA7
 67
 M
 NA
 0.810
 49.5
 -
 -
 -
CR1
 35
 F
 1.2
 0.741
 45.9
 Focal cortical dysplasia
 Yes
 Complex partial, GM
CR2
 31
 F
 1.3
 0.741
 39.5
 Focal cortical dysplasia
 Yes
 Simple partial
CR3
 9
 F
 NA
 0.607
 45.6
 Focal cortical dysplasia
 Yes
 Complex partial
CR4
 37
 M
 NA
 0.674
 43.7
 Focal cortical dysplasia
 Yes
 Complex partial
CR5
 35
 F
 NA
 0.737
 48.8
 Focal cortical dysplasia
 Yes
 Complex partial, GM
CR6
 31
 F
 NA
 0.674
 43.1
 Focal cortical dysplasia
 Yes
 Simple partial

*Sample names: position one = brain region (H, hippocampus; C, cortex); position two = sample source (A, autopsy; R, resection); position three = individual. †Ribosomal RNA bands ratio was measured using Agilent 2100 Bionalyzer system. ‡GAPDH ratio was measured using probes to 5' and 3' of the transcript on Affymetrix® array. §Expressed probesets were defined based on detection p < 0.05. F, female; GM, grand mal; M, male; NA, not applicable.

Franz et al. Genome Biology 2005 6:R112   doi:10.1186/gb-2005-6-13-r112